Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced a decision from its board to proceed with a capital reduction in its subsidiary, Guangzhou Baiyun Toothpaste Co., Ltd. This move follows the withdrawal of Meichen Group from the joint venture, as the latter failed to fulfill its initial capital contribution. Consequently, Guangzhou Baiyunshan will now hold 100% equity in the toothpaste company, indicating a strategic shift to consolidate its control and streamline operations in alignment with its future development plans.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company operates in the pharmaceutical industry, focusing on the production and distribution of medicinal products. It is known for its comprehensive range of healthcare solutions, targeting both domestic and international markets.
YTD Price Performance: -2.62%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.69B
Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.
